Lotus Pharmaceuticals Inc (PK) (LTUS) Quote

LTUS .0038

LTUS .003

LTUS .0006

LTUS SECURITY DETAILS fantastic float now
Share Structure
Market Cap Market Cap
24,250,640
08/03/2022
Authorized Shares
3,000,000,000
08/03/2022
Outstanding Shares
2,694,515,543 250m gone
08/03/2022
Restricted
2,681,123,970
08/03/2022
Unrestricted
13,391,573 250m gone from float as well
08/03/2022
Held at DTC
12,913,385
08/03/2022 Authorized Shares
3,000,000,000
11/28/2021
Outstanding Shares
2,944,515,543
11/28/2021
Restricted
2,681,123,970
11/28/2021
Unrestricted
263,391,573
11/28/2021

BUSINESS DESCRIPTION
Lotus Pharmaceuticals, Inc. is a development stage company actively seeking an acquisition partner in a 21st century emerging growth industry company.

LTUS SECURITY DETAILS
Share Structure
Market Cap Market Cap
68,459,986
11/26/2021
Authorized Shares
3,000,000,000
11/28/2021
Outstanding Shares
2,944,515,543
11/28/2021
Restricted
2,681,123,970
11/28/2021
Unrestricted
263,391,573
11/28/2021
Held at DTC
12,903,385
11/28/2021

no clue. I am seeing $10-20k bids last week or so. 13M held at DTC, Pink Current. https://www.otcmarkets.com/stock/LTUS/security

Here we go again. Anyone know what's going on?

LTUS Pink Current Today
https://www.otcmarkets.com/stock/LTUS/disclosure

They state in the quarterly report that this is the first time since 2014 that they are able to pay a dividend? I hope this is true!

https://www.lotuspharm.com/
Look at news and the quarterly report released today.

Earnings Released today

https://www.lotuspharm.com/Media/lotus-q121-earningsen-callsent.pdf

Great update today!!! Looking forward to news $LTUS https://www.otcmarkets.com/stock/LTUS/news/Lotus-Looking-at-Land-Development?id=301689

Very nice news didn’t see this until now $LTUS

Very Big News!!

https://finance.yahoo.com/news/lotus-pharmaceuticals-inc-current-otc-121200677.html

NEWSROOM
MONTHLY SALES REPORT FOR FEB 2021
POSTED ON 10.3.2021
Lotus today announced that its consolidated sales for February 2021 was NT$1,015,941 thousand, delivering a 95.4% growth over the same period last year. Its consolidated sales YTD’21 has increased by 75.8% YoY and reached NT$2.2 billion.

Up 125% in two days. Closed on the High!

Lotus Pharmaceutical filing Nashville TN USA office

https://marketexclusive.com/lotus-pharmaceuticals-inc-otcmktsltus-files-an-8-k-other-events/2020/02/

Very nice close today!!! What a move!!! $LTUS

https://www.stockscores.com/chart.asp?TickerSymbol=ltus&TimeRange=1825&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

wow

Selling at 1.45X Earnings?


Is it true that this is selling for this very very low PE?

Up 85%?

I have had this stock for years!!! It was up as much as 85% today?
Does anybody know what is going on?

Good close today $LTUS

Nice Green Day so far!!! $LTUS

Was a great day up until somebody dumped those 10K shares at the bid $LTUS

Looking good today good morning everyone $LTUS

Bought more $LTUS

Somebody is loading this one big time here. $LTUS

Thank you yes DM me $LTUS

$LTUS : Got another banger for you..............


If you're interested in it.


I can tell you later.


But make sure you confirm you get before you alert the masses.



Will only send in PM but I've been on it.



GO $LTUS

It’s definitely an undiscovered gem one of the most beautiful $LTUS

$LTUS: It is .............


Almost as beautiful as $NATUF



But thats just me.......... people see ROUGH......... I only see Diamonds.



One by one they unearth themselves and then people follow afterwards



GO $LTUS

What a beauty this one, added $LTUS

Highest volume since 4/10/2012
Today volume 1,138,000 so far, had touched 2,000,000 shares back then at $0.179 price.
Hmmm :)

$LTUS: Huge volume going here.......... lets go


Gonna run to $1



GO $LTUS

very high potential with an addition of a few backers

LTUS with a verified profile on OTC markets. Looks like updates are on the way.

Anyone figure out who the new CEO is? All I come up with is a guy out of Nashville who is building up a rehab and just raised over a hundred grand this week in a charity concert. I reached out but no response yet.

LaPus Pharma just popped like a zit.

LTUS New officers posted on NEV SOS

https://esos.nv.gov/EntitySearch/BusinessFilingHistroy?businessid=505279

https://www.otcmarkets.com/stock/LTUS/profile

LTUS would have to have the only drug which cures cancer for me to get my money to even.

WILL MAKE LTUS MILLIONS YEARLY

Hacho Hathcikian, Executive Vice President at Alvogen in the CEE regions, said: “The Lenalidomide launch is a major landmark for Alvogen in the CEE region as we are the first generic pharmaceutical company to launch the generic of Revlimid™ in our major markets. Patients now finally have access to an affordable and high-quality generic alternative of this leading oncology drug. Adding Lenalidomide to our portfolio also enhances our commitment to be one of the key oncology players in the CEE region.”

Revlimid™ is indicated for several hematological malignancies including multiple myeloma and is the biggest-selling oncology drug with approximately $9.8 billion sales globally.

Revlimid™ is a trademark of Celgene Corporation

FEBRUARY 12, 2019
Alvogen
launches
the
first
generic
equivalent
to
Revlimid™
in
Europe
Alvogen today announced the launch of the first generic equivalent of Revlimid™ (lenalidomide) in several CEE markets including Romania, Croatia, Bulgaria and the Baltic states. The product will be marketed as 2.5, 5, 7.5, 10, 15, 20, 25mg hard capsules and is a fully generic and bioequivalent product to Revlimid™. Following the launch into multiple CEE countries, Alvogen’s Lenalidomide will also be launched in selected Asian countries in 2019.

Alvogen’s Lenalidomide has been developed fully in-house at Alvogen‘s subsidiary, Lotus Pharmaceuticals and is part of a comprehensive oncology pipeline

https://alvogen.com/newsroom/alvogen-and-lotus-launch-the-first-generic-equivalent-to-revlimid

$LTUS Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, $5B COMPANY https://alvogen.com/newsroom

I have been sitting on shares for a year or so and noticed some movement. What do you think this means.

LTUS Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, $5B COMPANY FEBRUARY 12, 2019
Alvogen
launches
the
first
generic
equivalent
to
Revlimid™
in
Europe
Alvogen today announced the launch of the first generic equivalent of Revlimid™ (lenalidomide) in several CEE markets including Romania, Croatia, Bulgaria and the Baltic states. The product will be marketed as 2.5, 5, 7.5, 10, 15, 20, 25mg hard capsules and is a fully generic and bioequivalent product to Revlimid™. Following the launch into multiple CEE countries, Alvogen’s Lenalidomide will also be launched in selected Asian countries in 2019.

Alvogen’s Lenalidomide has been developed fully in-house at Alvogen‘s subsidiary, Lotus Pharmaceuticals and is part of a comprehensive oncology pipeline.

It's OK. The BEST is yet to come

.0165